Creative Planning Cuts Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Creative Planning cut its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 6.7% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 17,603 shares of the company’s stock after selling 1,259 shares during the quarter. Creative Planning’s holdings in Option Care Health were worth $488,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Harbor Capital Advisors Inc. boosted its stake in shares of Option Care Health by 317.9% during the second quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company’s stock valued at $2,670,000 after purchasing an additional 73,312 shares during the period. Rheos Capital Works Inc. boosted its stake in shares of Option Care Health by 9.8% during the first quarter. Rheos Capital Works Inc. now owns 357,600 shares of the company’s stock valued at $11,994,000 after purchasing an additional 32,000 shares during the period. Vanguard Group Inc. boosted its stake in shares of Option Care Health by 1.6% during the fourth quarter. Vanguard Group Inc. now owns 19,626,205 shares of the company’s stock valued at $661,207,000 after purchasing an additional 306,853 shares during the period. Comerica Bank boosted its stake in shares of Option Care Health by 6.5% during the first quarter. Comerica Bank now owns 760,915 shares of the company’s stock valued at $25,521,000 after purchasing an additional 46,639 shares during the period. Finally, Janus Henderson Group PLC boosted its stake in shares of Option Care Health by 182.9% during the first quarter. Janus Henderson Group PLC now owns 227,135 shares of the company’s stock valued at $7,617,000 after purchasing an additional 146,837 shares during the period. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Trading Up 0.1 %

Shares of OPCH stock opened at $30.61 on Wednesday. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.76 and a quick ratio of 1.36. The company has a market cap of $5.32 billion, a price-to-earnings ratio of 20.14, a PEG ratio of 2.21 and a beta of 1.29. The stock has a 50 day simple moving average of $31.00 and a 200-day simple moving average of $30.15. Option Care Health, Inc. has a 1-year low of $26.11 and a 1-year high of $34.63.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Wednesday, July 31st. The company reported $0.30 EPS for the quarter, beating the consensus estimate of $0.27 by $0.03. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. The firm had revenue of $1.23 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same period in the prior year, the company earned $0.63 EPS. The firm’s revenue was up 14.8% compared to the same quarter last year. On average, equities research analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Insider Activity at Option Care Health

In related news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the transaction, the chief financial officer now directly owns 247,317 shares in the company, valued at $7,654,461.15. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the sale, the chief financial officer now owns 247,317 shares of the company’s stock, valued at $7,654,461.15. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now directly owns 21,339 shares in the company, valued at $663,429.51. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

OPCH has been the subject of several recent research reports. JMP Securities lifted their price objective on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a report on Monday, September 30th. Barrington Research lifted their price objective on Option Care Health from $38.00 to $40.00 and gave the company an “outperform” rating in a report on Thursday, August 1st.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.